<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Hypertension | Family Medicine Reference</title>
  <style>
    body {
      font-family: "Segoe UI", Tahoma, Geneva, Verdana, sans-serif;
      background-color: #f8f9fa;
      color: #212529;
      line-height: 1.6;
      margin: 40px;
    }
    h1, h2, h3 {
      color: #004085;
    }
    section {
      background: #ffffff;
      border-radius: 8px;
      box-shadow: 0 2px 5px rgba(0,0,0,0.1);
      padding: 25px;
      margin-bottom: 20px;
    }
    table {
      width: 100%;
      border-collapse: collapse;
      margin: 10px 0;
    }
    th, td {
      border: 1px solid #dee2e6;
      padding: 10px;
      text-align: left;
    }
    th {
      background-color: #e9ecef;
    }
    .source {
      font-size: 0.9em;
      color: #555;
    }
    a {
      color: #0069d9;
      text-decoration: none;
    }
    a:hover {
      text-decoration: underline;
    }
  </style>
</head>
<body>

  <h1>Hypertension (HTN)</h1>
  <section>
    <h2>Definition</h2>
    <p>
      Hypertension is defined as persistently elevated blood pressure. According to the 
      2017 ACC/AHA guidelines, hypertension in adults is diagnosed when 
      <strong>blood pressure ≥ 130/80 mmHg</strong>.  
      The JNC 8 guidelines define it as <strong>≥ 140/90 mmHg</strong>.
    </p>
  </section>

  <section>
    <h2>Classification</h2>
    <ul>
      <li><strong>Primary (Essential) Hypertension:</strong> ~90% of cases, no identifiable cause.</li>
      <li><strong>Secondary Hypertension:</strong> due to an underlying disease (renal, endocrine, vascular).</li>
    </ul>
  </section>

  <section>
    <h2>Common Causes of Secondary Hypertension</h2>
    <ul>
      <li>Chronic kidney disease</li>
      <li>Primary hyperaldosteronism</li>
      <li>Renal artery stenosis</li>
      <li>Coarctation of the aorta</li>
      <li>Endocrine disorders (e.g., Cushing’s, pheochromocytoma, thyroid disease)</li>
    </ul>
  </section>

  <section>
    <h2>Clinical Features</h2>
    <ul>
      <li>Often asymptomatic until organ damage occurs.</li>
      <li>Possible early symptoms: headache, dizziness, tinnitus, chest discomfort.</li>
    </ul>
    <p><strong>Target organs affected:</strong> brain, heart, kidneys, eyes (e.g., retinopathy, stroke, MI).</p>
  </section>

  <section>
    <h2>Diagnosis</h2>
    <ul>
      <li>Persistent elevated BP on ≥2 separate occasions in the office.</li>
      <li>Confirm with out-of-office BP measurement (home or ambulatory monitoring).</li>
      <li>Assess cardiovascular risk and screen for end-organ damage.</li>
      <li>Investigate secondary causes if suspected.</li>
    </ul>
    <table>
      <tr>
        <th>Test</th>
        <th>Purpose</th>
      </tr>
      <tr>
        <td>Basic metabolic panel (electrolytes, creatinine)</td>
        <td>Evaluate renal function and electrolytes.</td>
      </tr>
      <tr>
        <td>Urinalysis</td>
        <td>Detect proteinuria or hematuria.</td>
      </tr>
      <tr>
        <td>Lipid panel</td>
        <td>Assess cardiovascular risk.</td>
      </tr>
      <tr>
        <td>ECG</td>
        <td>Detect LV hypertrophy or arrhythmias.</td>
      </tr>
      <tr>
        <td>Fundoscopic exam</td>
        <td>Look for hypertensive retinopathy.</td>
      </tr>
    </table>
  </section>

  <section>
    <h2>Treatment</h2>
    <h3>1. Lifestyle Modifications</h3>
    <ul>
      <li>Weight reduction and regular exercise.</li>
      <li>DASH diet (low sodium, high fruits/vegetables).</li>
      <li>Limit alcohol intake and quit smoking.</li>
    </ul>

    <h3>2. Pharmacologic Therapy</h3>
    <ul>
      <li><strong>First-line agents:</strong> ACE inhibitors, ARBs, thiazide diuretics, calcium channel blockers.</li>
      <li>Drug choice depends on comorbidities and patient characteristics.</li>
      <li>Example starting doses (general adult):</li>
    </ul>
    <table>
      <tr><th>Medication</th><th>Typical Starting Dose</th></tr>
      <tr><td>Lisinopril (ACEI)</td><td>10 mg once daily</td></tr>
      <tr><td>Losartan (ARB)</td><td>50 mg once daily</td></tr>
      <tr><td>Amlodipine (CCB)</td><td>5 mg once daily</td></tr>
      <tr><td>Hydrochlorothiazide</td><td>12.5–25 mg once daily</td></tr>
    </table>

    <p><strong>Note:</strong> Drug selection and titration must be individualized. Some drugs are contraindicated in pregnancy and pediatric patients.</p>
  </section>

  <section>
    <h2>Complications</h2>
    <ul>
      <li>Myocardial infarction</li>
      <li>Stroke</li>
      <li>Chronic kidney disease</li>
      <li>Retinopathy</li>
      <li>Heart failure (especially diastolic)</li>
    </ul>
  </section>

  <section>
    <h2>Follow-Up and Monitoring</h2>
    <ul>
      <li>Reassess BP every 1–3 months after initiation or adjustment of therapy.</li>
      <li>Monitor for side effects (electrolyte changes, renal function, orthostatic hypotension).</li>
    </ul>
  </section>

  <p class="source">
    Source: <a href="https://www.amboss.com/us/knowledge/hypertension?utm_medium=chatgpt-plugin&utm_source=chatgpt" target="_blank">
    AMBOSS: Hypertension</a>
  </p>

</body>
</html>
